SCHEMBL10244068

SCHEMBL10244068

O=C(c1ccc2nn[nH]c2c1)N1[C@@H]2CC[C@H]1C[C@@H](c1ccc(F)cc1)C2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 2/20 0.42
SIGMAR1 Q99720 2/20 0.42
KDM1A O60341 2/20 0.40
POLB P06746 1/20 0.40
DRD2 P14416 3/20 0.39
DRD4 P21917 3/20 0.39
HTR1A P08908 2/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
HRH1 P35367 1/20 0.39
CCNC P24863 3/20 0.39
CDK8 P49336 3/20 0.39
NAMPT P43490 2/20 0.38
HRH3 Q9Y5N1 1/20 0.38
TRPC6 Q9Y210 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 1/20 0.35
PROKR1 Q8TCW9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17350974 1.00 SLC18A3 (0.42) SLC18A3SIGMAR1KDM1APOLBDRD2
SCHEMBL17350840 0.81 HSP90AA1 (0.47) SLC18A3SIGMAR1KDM1APOLBNAMPT
SCHEMBL10243810 0.81 HSP90AA1 (0.47) SLC18A3SIGMAR1KDM1APOLBNAMPT
SCHEMBL17351078 0.80 KDM1A (0.48) SLC18A3SIGMAR1KDM1APOLBDRD2
SCHEMBL10243740 0.80 KDM1A (0.48) SLC18A3SIGMAR1KDM1APOLBDRD2
SCHEMBL10243883 0.80 POLB (0.57) SLC18A3SIGMAR1KDM1APOLBDRD2
SCHEMBL17350984 0.80 POLB (0.57) SLC18A3SIGMAR1KDM1APOLBDRD2
SCHEMBL10243769 0.79 ESR1 (0.49) SLC18A3SIGMAR1KDM1APOLBDRD2
SCHEMBL17350911 0.79 ESR1 (0.49) SLC18A3SIGMAR1KDM1APOLBDRD2
SCHEMBL2682867 0.79 CTNNB1 (0.52) SLC18A3SIGMAR1KDM1APOLBCCNC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2318403-B1 Aryl- and heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use BOEHRINGER INGELHEIM INT (DE) 2015-12-23 EP disclosed
US-20120115853-A1 Aryl- and Heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120115853-A1 Aryl- and Heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use HSD11B1, HSD11B2, HSD17B1 SLC18A3 3630/4885SIGMAR1 277/4885KDM1A 1654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.